Skip to main content

Table 1 Characteristics of the study population

From: Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin

  Baseline 3 monthFollow-up Δ P-value
  (n = 20) (n = 20)   
Age [Years] 46.5 ± 11.2    
Sex [M/F] 2/18    
Metabolic Syndrome [n (%)] 13 (65%) 2 (10%)   
NASH [n (%)] 13 (65%) 11 (55%)   
Haemoglobin [mmol l−1] 8.5 ± 0.5 8.4 ± 0.6 −0.1 ± 0.4 0.1405
Weight [kg] 118 (108.75; 127) 94 (84.7; 100) −23.33 ± 4.21 0.0001
BMI [kg m− 2] 42.1 (40.4; 44.1) 33.9 (32.0; 35.0) −8.4 ± 1.4 < 0.0001
Total Fat Mass [kg] 54.8 ± 11.0 40.2 (32.9; 42.3) −15.6 ± 35. 6 < 0.0001
Body Fat Percentage [%] 45.3 ± 4.9 39.4 ± 6.5 −5.6 ± 2.4 < 0.0001
Fat Mass/Fat Free Mass [AU] 0.84 ± 0.16 0.67 ± 0.17 −0.16 ± 0.06 < 0.0001
Android Fat [kg] 48.2 ± 8.2 31.9 ± 9.6 −16.8 ± 4.7 < 0.0001
Android Fat Percentage [%] 46.8 ± 4.0 39.5 ± 6.0 −7.3 ± 3.8 < 0.0001
Truncal Fat [kg] 26.6 ± 40.3 17.9 ± 49.2 −8.4 ± 2.9 < 0.0001
Truncal Fat Percentage [%] 44.5 ± 3.7 37.5 ± 6.4 −6.6 ± 3.9 < 0.0001
Total Cholesterol [mmol l−1] 4.92 ± 1.00 4.49 ± 0.88 −0.44 ± 0.82 0.0275
HDL Cholesterol [mmol l−1] 1.14 ± 0.27 1.12 ± 0.28 −0.02 ± 0.15 0.659
LDL Cholesterol [mmol l−1] 2.99 ± 0.87 2.82 ± 0.69 −0.18 ± 0.73 0.2992
Oxidized LDL Cholesterol 4.53 ± 1.13 4.34 ± 0.93 −0.19 ± 0.84 0.3203
Triglycerides [mmol l−1] 1.72 ± 0.62 1.15 (1.05; 1.45) −0.46 ± 0.52 0.001
Triglyceride/HDL [AU] 1.38 (1.09; 1.89) 1.03 (0.86; 1.41) −0.41 ± 0.54 0.0023
Glycated Haemoglobin [%] 5.9 ± 0.43 5.6 (5.5; 5.8) −0.14 ± 0.40 0.0792
Fasting Glucose [mmol l−1] 5.45 (5.18; 6.03) 5.1 (4.78; 5.33) −0.45 (− 0.8; − 0.15) 0.0157
Fasting C-Peptide [pmol l− 1] 1061 (921; 1422) 745 (566; 935) − 360 (− 542; −36.3) 0.0094
Fasting Insulin [pmol l− 1] 131.7 (97.5; 201.5) 63.7 (53.7; 77.8) −69.7 (− 105.7; −40.8) 0.0014
HOMAIR 2.55 (2.05; 3.2) 1.6 (1.3; 2.05) −0.85 (− 1.43; − 0.075) 0.0149
HOMASE 42.7 ± 16.4 60.4 ± 20.7 17.7 ± 26.3 0.0072
YKL40 [ng ml−1] 57.5 (47; 68.3) 58 (45; 72.8) 1.1 ± 14.8 1
Liver Fat Percentage [%] 6.7 (4.54; 9.99) 2.82 (2.23; 3.79) −2.78 (−6.23; −1.84) 0.0002
ALT [U I−1] 30.9 ± 13.6 29.4 ± 15.8 −1.45 ± 20.4 0.7537
AST [U I−1] 28 (25; 32.3) 26 (22; 37) 0.65 ± 12.1 0.9826
AST/ALT [AU] 0.97 (0.88; 1.36) 0.97 (0.92; 1.24) 0.06 (−0.11; 0.30) 0.33
Leukocytes [mia l−1] 8.37 ± 2.24 6.65 (5.73; 8.08) −1.34 ± 1.15 0.0003
High-sensitivity CRP [mg l−1] 4.67 (2.78; 9.99) 2.16 (1.28; 5.16) −3.91 ± 6.15 0.0073
Soluble CD36 [AU] 0.48 ± 0.20 0.37 (0.24; 0.40) −0.13 (−0.19; − 0.06) 0.0008
  1. Data are depicted as mean ± SD or median (Q25%; Q75%)
  2. p-values < 0.05 in bold text